<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.958" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">447</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 100.160 L115.850 100.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 589.160 L103.610 589.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P866</text>
   <text y="87.957" x="62.362,67.861,71.857,75.853,79.354,81.856,85.357,88.354,92.35,97.354,101.35,105.346,107.596,112.096,115.093,117.343,121.843,128.341,134.839,137.089,139.591,144.595,146.845,153.343,158.347,163.846,166.096,170.596,173.593,175.843,184.339,189.343,191.593,196.597,201.097,204.094,206.596,210.592,215.596,218.593,222.094,224.344,230.842,233.344,236.341,241.345,243.595,249.094,257.59" svgx:width="0.61,0.44,0.44,0.39,0.28,0.39,0.33,0.44,0.56,0.44,0.44,0.25,0.5,0.33,0.25,0.5,0.72,0.72,0.25,0.28,0.56,0.25,0.72,0.56,0.61,0.25,0.5,0.33,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.72,0.28,0.33,0.56,0.25,0.61,0.94,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Persistence of JCV in CSF of MS patients with PML</text>
   <text y="98.955" x="62.362,68.86,71.11,75.61,80.11,84.61,86.86,93.358,97.354,99.856,104.356,108.352,111.349" svgx:width="0.72,0.25,0.5,0.5,0.5,0.25,0.72,0.44,0.28,0.5,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">G von Geldern</text>
   <text y="96.439" x="115.849,118.774,120.236" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="98.959" x="123.161,125.411,127.661,133.664,135.914,141.917,146.417,149.918,153.914,158.414,162.914,166.91,173.408,175.91,178.412,181.913,185.909" svgx:width="0.25,0.25,0.67,0.25,0.67,0.5,0.39,0.44,0.5,0.5,0.44,0.72,0.28,0.28,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Ryschkewitsch</text>
   <text y="96.439" x="190.408" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="98.959" x="193.333,195.583,197.833,205.834,211.837,214.087,222.088,226.588,231.088,235.084,239.08" svgx:width="0.25,0.25,0.89,0.67,0.25,0.89,0.5,0.5,0.44,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MC Monaco</text>
   <text y="96.439" x="243.58" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="98.959" x="246.505,248.755,251.005,256.009" svgx:width="0.25,0.25,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P </text>
   <text y="109.957" x="62.365,65.866,69.862,74.362,77.863,81.859" svgx:width="0.39,0.44,0.5,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Jensen</text>
   <text y="107.439" x="86.356" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="109.959" x="89.281,91.531,93.781,100.279,102.529,109.027,113.023,115.525" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Nath</text>
   <text y="107.439" x="120.024" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="109.959" x="122.949,125.199,127.449,132.948,139.446,141.696,149.697,153.693,156.195,160.695" svgx:width="0.25,0.25,0.61,0.72,0.25,0.89,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, EO Major</text>
   <text y="107.439" x="163.692" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="118.437" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,121.78,126.28,129.781,134.281,136.783,141.283,145.783,148.285,152.785,157.285,159.535,161.785,167.788,171.784,176.284,179.785,184.285,186.787,191.287,195.787,199.783,202.033,204.283,211.78,216.28,218.782,221.284,223.786,228.286,230.788,234.784,237.034,241.534,245.53,248.032,252.028,255.529,260.029,263.53,266.032,269.533" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Washington, Neurology, Multiple Sclerosis </text>
   <text y="131.957" x="62.362,68.365,72.361,76.861,79.363,83.359,86.86,89.11,91.36,95.86,99.856,104.356,106.858,109.36,111.862,115.858,118.108,120.358,127.855,133.354,135.604,137.854,144.352,148.852,151.354,153.856,157.852,162.352,164.602,169.102,171.604,176.104,178.606,182.602,186.103,188.353" svgx:width="0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.5,0.44,0.5,0.28,0.28,0.28,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Center, Seattle, WA, United States, </text>
   <text y="129.439" x="190.602" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="131.959" x="193.527,199.53,204.03,206.532,209.034,213.534,218.034,222.534,225.036,227.286,230.283,234.783,238.284,240.786,243.288,245.79,250.29,252.792,256.788,260.289,262.539,267.039,269.541" svgx:width="0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">National Institutes of </text>
   <text y="142.957" x="62.361,68.859,72.855,77.355,79.857,82.359,86.859,89.109,91.359,97.362,101.862,104.364,106.866,111.366,115.866,120.366,122.868,125.118,128.115,132.615,136.116,138.618,141.12,143.622,148.122,150.624,154.62,156.87,161.37,163.872,166.122,172.125,176.121,180.621,184.122,188.622,191.124,195.624,200.124,202.626,206.622,211.122,213.624,215.874,222.372,224.874,228.375,232.875,236.376,240.876,244.872,248.373,251.874,254.124,258.624,263.124,267.624,269.874,274.374,276.876,280.377,284.877,288.873,292.869,295.119" svgx:width="0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.72,0.28,0.39,0.5,0.39,0.5,0.44,0.39,0.39,0.25,0.5,0.5,0.5,0.25,0.5,0.28,0.39,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Health, National Institute of Neurological Disorders and Stroke, </text>
   <text y="153.955" x="62.361,66.861,70.857,74.853,77.355,79.857,84.357,88.857,91.107,95.607,98.109,100.359,103.356,107.856,110.358,114.354,118.35,120.852,123.354,127.854,132.354,135.855,138.105,142.605,145.107,147.357,149.859,154.359,158.355,160.605,166.608,170.604,174.105,178.101,182.601,187.101,190.602,192.852,197.352,201.348,204.849,207.351,211.347,217.845,220.095,222.345,227.844,231.84,234.342,238.842,242.838,246.339,250.839,255.339,257.589,259.839,267.336,273.834,276.084" svgx:width="0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.25,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.67,0.44,0.39,0.44,0.5,0.5,0.39,0.25,0.5,0.44,0.39,0.28,0.44,0.72,0.25,0.25,0.61,0.44,0.28,0.5,0.44,0.39,0.5,0.5,0.25,0.25,0.83,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Section of Infections of the Nervous System, Bethesda, MD, </text>
   <text y="164.953" x="62.361,68.859,73.359,75.861,78.363,82.359,86.859,89.109,93.609,96.111,100.611,103.113,107.109,110.61,112.86" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United States, </text>
   <text y="162.439" x="115.111" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="164.959" x="118.036,124.039,128.539,131.041,133.543,138.043,142.543,147.043,149.545,151.795,154.792,159.292,162.793,165.295,167.797,170.299,174.799,177.301,181.297,184.798,187.048,191.548,194.05,196.3,202.798,206.794,211.294,213.796,216.298,220.798,223.048,225.298,231.301,235.801,238.303,240.805,245.305,249.805,254.305,256.807,259.057,262.054,266.554,270.055,272.557,275.059,277.561,282.061,284.563,288.559" svgx:width="0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.25,0.72,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">National Institutes of Health, National Institute </text>
   <text y="175.957" x="62.362,66.862,69.364,71.614,77.617,81.613,86.113,89.614,94.114,96.616,101.116,105.616,108.118,112.114,116.614,119.116,121.366,127.864,130.366,133.867,138.367,141.868,146.368,150.364,153.865,157.366,159.616,164.116,168.616,173.116,175.366,179.866,182.368,185.869,190.369,194.365,198.361,200.611,202.861,207.865,212.365,216.865,221.365,224.866,229.366,231.868,236.368,239.869,243.865,246.115,250.615,253.117,255.367,262.864,267.364,269.866,273.862,277.858,282.358,284.86,289.36,292.861" svgx:width="0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.72,0.28,0.39,0.5,0.39,0.5,0.44,0.39,0.39,0.25,0.5,0.5,0.5,0.25,0.5,0.28,0.39,0.5,0.44,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.28,0.44,0.44,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">of Neurological Disorders and Stroke, Laboratory of Molecular </text>
   <text y="186.955" x="62.362,69.859,73.855,78.355,80.857,84.853,87.355,91.855,95.851,98.101,102.601,107.101,111.601,113.851,119.854,123.85,128.35,131.851,136.351,139.852,143.848,146.35,150.346,154.846,158.842,162.838,165.088,167.338,172.837,176.833,179.335,183.835,187.831,191.332,195.832,200.332,202.582,204.832,212.329,218.827,221.077,223.327,229.825,234.325,236.827,239.329,243.325,247.825,250.075,254.575,257.077,261.577,264.079,268.075" svgx:width="0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.61,0.44,0.28,0.5,0.44,0.39,0.5,0.5,0.25,0.25,0.83,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Medicine and Neuroscience, Bethesda, MD, United States</text>
   <text y="213.955" x="62.362,68.41,72.955,76.996,82.045,86.59,90.469,95.014,100.063,105.112,110.161,113.203" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="213.955" x="118.801,126.847,131.392,133.939,136.486,139.033,143.578,146.125,150.166,152.416,155.764,159.31,163.351,165.898,169.939,172.981,177.526,181.072,183.619,187.165,189.415,192.763,195.805,203.851,208.9,211.942,214.192,217.54,222.085,226.126,228.673,231.22,235.261,239.806,242.353,245.899,248.149,251.497,254.044,257.086,261.127,265.168,267.715,271.756,276.301,278.551,281.899,288.442,290.989,293.536,298.036" svgx:width="0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Multiple sclerosis (MS) patients treated with </text>
   <text y="224.953" x="62.362,66.907,70.948,73.495,77.536,80.083,82.63,86.671,91.216,98.263,102.304,106.849,109.099,110.818,114.859,117.901,121.942,124.192,125.911,129.952,132.499,134.749,136.468,139.51,142.057,145.603,150.148,152.398,154.117,157.159,161.704,164.746,166.996,168.715,173.26,177.301,181.846,185.887,188.434,192.979,197.524,200.071,204.616,209.161,211.411,213.13,218.179,221.221,225.766,230.311,233.353,237.394,240.94,244.486,247.033,251.578,255.619,257.869,259.588,267.634,272.179,274.726,277.273,279.82,282.862,287.407,291.448,295.489,297.991" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.28,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.56,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab are at risk for developing Progressive Multifocal </text>
   <text y="235.951" x="62.362,67.861,71.857,76.357,80.857,85.357,89.353,93.853,97.849,101.845,106.345,110.845,114.841,117.343,121.843,126.343,130.339,132.841,137.341,141.841,144.091,146.494,149.491,154.495,162.496,167.995,170.992,173.242,175.492,177.895,181.891,184.141,186.544,191.044,195.04,202.042,206.542,210.538,213.04,215.542,220.042,224.038,226.54,229.042,233.542,238.042,240.292,242.695,247.195,249.697,253.198,257.194,261.19,264.691,268.687,270.937,273.34,277.84,282.34,286.336,288.586,290.989,293.491,297.991" svgx:width="0.61,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.89,0.61,0.33,0.25,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Leukoencephalopathy (PML), a demyelinating disease due to </text>
   <text y="246.949" x="62.362,64.864,69.364,72.361,76.357,80.353,82.855,85.357,89.857,94.357,96.571,103.069,105.571,108.073,112.573,114.787,118.288,124.291,126.496,130.996,133.498,136.495,140.995,144.496,146.71,149.707,153.208,159.211,165.709,168.706,170.956,173.17,178.174,181.171,185.167,188.668,192.664,197.164,201.16,205.156,207.361,211.861,214.858,217.072,220.573,226.576,232.912,235.126,237.628,242.128,244.342,246.844,251.344,255.34,257.554,261.55,265.546,268.543,272.539,277.039,280.036,284.536,288.037,292.537,295.039" svgx:width="0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.33,0.39,0.67,0.72,0.33,0.25,0.25,0.56,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.33,0.44,0.5,0.33,0.5,0.39,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">infection with JC virus (JCV). Presence of JCV in the cerebrospi-</text>
   <text y="257.947" x="62.362,66.862,70.858,73.36,75.61,76.312,79.309,81.811,86.311,88.813,93.313,95.563,96.265,99.262,105.265,110.269,115.273,118.27,120.52,121.222,123.724,127.225,129.475,130.177,134.173,138.673,140.923,141.625,144.127,151.129,155.629,160.129,163.126,165.628,169.624,174.124,176.626,178.876,179.578,182.575,185.077,189.577,194.077,196.579,201.079,205.579,207.829,208.531,211.033,215.533,217.783,218.485,220.987,225.487,229.483,231.733,232.435,236.935,239.437,243.433,247.933,252.433,256.933,260.434,262.936,266.437,268.687,269.389,273.889,276.886,279.136,279.838,284.842,292.843,298.009" svgx:width="0.5,0.44,0.28,0.25,0.55,0.33,0.28,0.5,0.28,0.5,0.25,0.55,0.33,0.67,0.56,0.56,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nal fluid (CSF) is an important finding in the diagnosis of PML </text>
   <text y="268.945" x="62.362,66.358,70.858,75.358,77.608,78.499,81.001,84.502,86.752,87.643,92.143,96.643,99.145,101.395,102.286,105.787,109.783,113.779,118.279,120.529,121.42,123.922,128.422,130.672,131.563,139.564,144.568,146.818,147.709,152.209,156.205,158.707,161.209,165.205,169.705,172.207,175.708,177.958,178.849,185.347,187.849,190.351,194.851,199.351,203.851,206.353,208.603,209.494,214.498,222.499,227.998,230.248,232.498,233.389,238.888,243.388,247.888,252.388,254.89,257.392,261.892,266.392,268.894,273.394,277.39,279.892,282.142,283.033,287.533,291.529,294.031,298.027" svgx:width="0.44,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.39,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.55,0.56,0.89,0.61,0.25,0.25,0.55,0.61,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and is not seen in MS patients without PML. Longitudinal data </text>
   <text y="279.943" x="62.362,64.864,69.364,73.864,77.86,81.361,83.863,86.365,90.865,94.861,97.363,99.865,104.365,108.865,111.178,113.68,118.18,122.176,124.489,128.485,130.987,134.983,138.979,141.976,145.972,150.472,154.468,158.464,160.777,165.277,168.274,170.587,174.088,180.091,186.427,188.74,191.737,194.734,199.234,206.236,208.549,211.051,215.551,219.547,221.86,227.863,232.867,237.871,240.184,242.686,247.186,249.499,254.503,262.504,267.67,269.983,274.483,278.479,280.981,283.483,287.479,291.979,294.481,297.982" svgx:width="0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.28,0.44,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.67,0.56,0.56,0.25,0.28,0.5,0.25,0.56,0.89,0.61,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">investigating the clearance of JCV from the CSF in PML patients </text>
   <text y="290.941" x="62.362,64.864,68.365,70.615,75.115,79.111,81.613,86.113,90.613,92.863,96.859,101.359,103.861,106.363,110.359,114.355,116.857,120.853,125.353,127.603,134.101,136.603,139.105,143.605,145.855,148.357,152.857,156.853,159.103,161.605,166.105,170.101,173.098,177.094,181.09,184.591,187.093,191.593,196.093,198.343,202.339,206.335,209.836,213.832,217.333,219.583,224.083,227.08,229.33,234.334,242.335,247.834" svgx:width="0.28,0.39,0.25,0.5,0.44,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.28,0.5,0.5,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">is being collected with the increasing cases of PML.</text>
   <text y="301.939" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="301.939" x="109.099,115.597,119.098,122.599,126.595,130.096,133.597,135.847,136.846,142.849,147.853,152.857,155.107,156.106,160.606,163.603,165.853,166.852,171.856,179.857,185.023,187.273,188.272,192.772,196.768,199.27,201.772,205.768,210.268,212.77,216.271,218.521,219.52,222.022,226.522,231.022,235.522,238.024,240.526,245.026,249.526,252.028,256.528,260.524,263.026,265.528,270.028,272.278,273.277,276.274,280.774,283.771,286.021,287.02,289.522,294.022,298.018" svgx:width="0.72,0.39,0.39,0.44,0.39,0.39,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Assess CSF of PML patients longitudinally for the </text>
   <text y="312.937" x="62.362,66.862,69.859,73.855,77.356,81.352,85.852,89.848,93.844,96.094,100.594,103.591,105.841,109.342,115.345,120.682" svgx:width="0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">presence of JCV.</text>
   <text y="323.935" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="323.935" x="102.295,108.298,113.302,118.306,120.556,121.744,124.741,127.738,132.238,139.24,141.49,142.687,147.187,151.687,153.937,155.125,163.126,168.13,170.38,171.577,176.077,180.073,182.575,185.077,189.073,193.573,196.075,199.576,201.826,203.014,207.514,210.016,214.012,218.512,223.012,227.512,231.013,235.009,239.509,241.759,242.947,249.445,251.947,254.449,258.949,261.199,262.387,267.391,275.392,280.558,282.808,283.996,290.494,294.49,297.991" svgx:width="0.67,0.56,0.56,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CSF from 65 MS patients diagnosed with PML was </text>
   <text y="334.933" x="62.362,64.864,68.86,72.361,74.863,78.859,83.359,85.609,86.347,90.343,92.845,95.095,95.833,98.335,102.331,106.327,109.828,112.33,114.58,115.318,119.818,124.318,128.314,132.31,134.56,135.298,139.294,142.291,144.793,148.789,151.786,154.036,154.774,157.276,161.776,164.278,166.78,169.282,173.278,175.78,178.03,178.768,183.268,185.77,189.766,194.266,198.766,203.266,206.767,209.269,212.77,215.02,217.27,218.008,224.011,228.007,232.507,236.503,240.499,243.001,245.251,245.989,251.992,256.996,262.0,264.25,264.988,268.489,272.485,279.487,283.987,286.489,288.991,293.491,297.991" svgx:width="0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.44,0.44,0.39,0.28,0.25,0.55,0.5,0.5,0.44,0.44,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.67,0.44,0.5,0.44,0.44,0.28,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tested at least once after initial diagnosis. Repeat CSF sampling </text>
   <text y="345.931" x="62.362,66.862,70.858,74.854,79.354,82.351,85.348,89.344,93.844,96.094,97.588,101.584,104.086,106.336,107.83,111.826,114.076,115.57,122.572,126.568,130.564,135.064,137.314,138.808,141.31,143.812,150.814,154.81,157.06,158.554,163.054,166.051,168.301,169.795,174.295,178.795,181.045,182.539,187.039,191.035,195.535,199.036,201.286,202.78,206.776,209.773,212.275,216.271,219.268,221.518,223.012,225.514,230.014,232.516,235.018,237.52,241.516,244.018,246.268,247.762,250.264,254.26,257.761,260.263,262.765,267.265,271.765,274.015,276.265,277.759,280.756,285.256,287.506,289.0,293.5,298.0" svgx:width="0.5,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.28,0.28,0.78,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.25,0.55,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">occurred at a mean time of 55 days after initial testing. In 36 </text>
   <text y="356.929" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.611,95.05,101.053,106.057,111.061,113.5,119.998,123.994,127.495,129.934,133.93,138.43,142.426,144.928,149.428,153.424,157.42,161.92,164.359,168.355,170.857,173.296,177.292,179.731,182.233,186.733,189.235,192.232,196.732,199.171,201.673,204.175,211.177,215.173,217.612,222.112,226.612,229.114,233.614,236.116,238.366,240.805,244.306,250.309,256.645,259.084,265.582,272.08,278.083,280.522,284.518,289.018,293.518,298.018" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.67,0.56,0.56,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.44,0.28,0.25,0.44,0.25,0.28,0.5,0.28,0.33,0.5,0.25,0.28,0.28,0.78,0.44,0.25,0.5,0.5,0.28,0.5,0.28,0.25,0.25,0.39,0.67,0.72,0.25,0.72,0.72,0.72,0.25,0.44,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients, CSF was analyzed at a third time point. JCV DNA copy </text>
   <text y="367.927" x="62.362,66.862,71.362,78.364,82.864,86.86,89.857,92.602,99.1,103.096,106.597,109.342,113.842,117.838,120.34,124.336,128.332,130.834,134.83,139.33,142.075,146.575,151.075,153.82,158.32,162.82,166.816,171.316,173.818,176.32,178.822,182.818,185.32,187.822,192.322,196.318,199.063,202.06,206.056,210.052,212.554,215.551,218.053,220.555,227.557,231.553,234.298,238.798,243.298,245.8,250.3,257.302,261.298,264.295,268.291,271.792,275.788,278.533,282.529,287.029,291.025,293.527,298.027" svgx:width="0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.44,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.44,0.28,0.33,0.28,0.28,0.78,0.44,0.25,0.5,0.5,0.28,0.5,0.78,0.44,0.33,0.44,0.39,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">number was detected by quantitative real-time polymerase chain </text>
   <text y="378.925" x="62.362,65.359,69.355,73.351,77.347,79.849,82.351,86.851,91.351,93.601,96.598,101.098,106.102,112.105,118.108,121.105,123.355,129.853,132.355,134.857,139.357,141.607,145.603,147.853,152.353,156.349,158.851,162.847,166.843,169.345,171.847,176.347,180.847,183.097,185.599,188.101,195.103,197.605,200.107,202.357,206.857,209.854,212.104,216.604,221.104,223.354,227.35,231.85,236.35,238.852,242.848,246.349,248.851,255.853,261.019,263.269,266.266,270.262,272.764,279.766,285.265,288.262" svgx:width="0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.56,0.67,0.67,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.28,0.78,0.28,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.44,0.39,0.28,0.78,0.61,0.25,0.33,0.44,0.28,0.78,0.61,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reaction (qPCR) with a detection limit of 10 copies/mL (c/mL).</text>
   <text y="389.923" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="389.923" x="95.788,98.785,103.285,105.715,110.215,114.715,117.217,121.717,126.217,128.647,131.644,136.144,140.644,148.141,151.138,153.568,158.068,161.065,163.495,165.997,170.497,174.493,176.923,181.423,185.419,187.921,190.423,194.419,198.919,201.421,204.922,207.352,210.853,216.856,223.192,225.622,232.12,238.618,244.621,247.051,251.047,255.547,260.047,264.547,266.977,271.477,275.977,282.979,287.479,291.475,294.472,297.973" svgx:width="0.33,0.5,0.25,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.67,0.72,0.25,0.72,0.72,0.72,0.25,0.44,0.5,0.5,0.5,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In 39/65 (60%) of the patients JCV DNA copy numbers </text>
   <text y="400.921" x="62.362,66.862,70.858,74.854,77.851,81.847,85.843,89.344,93.34,97.84,100.09,101.458,105.454,108.451,110.953,114.949,117.946,120.196,121.564,124.066,128.566,131.068,133.57,136.072,140.068,142.57,144.82,146.188,150.688,153.19,157.186,161.686,166.186,170.686,174.187,176.689,180.19,182.44,184.69,186.058,189.055,193.555,195.805,197.173,199.675,206.173,210.169,212.671,217.171,221.167,223.417,224.785,229.285,232.282,234.532,235.9,238.402,242.902,246.898,250.399,254.395,256.645,258.013,260.515,265.015,269.515,272.017,276.517,279.019,283.519,288.019,292.015,294.517,298.018" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.28,0.72,0.44,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decreased after initial diagnosis. In twelve of these individuals </text>
   <text y="411.919" x="62.362,65.359,69.859,74.359,81.856,84.853,87.202,90.703,96.706,103.042,105.391,111.889,118.387,124.39,126.739,133.237,137.233,140.734,143.083,147.583,152.083,156.583,160.579,163.081,167.077,171.073,173.575,177.571,182.071,184.573,188.569,190.918,194.914,197.416,199.765,202.267,206.767,210.763,213.112,215.614,218.116,225.118,229.114,231.463,235.963,238.96,241.309,243.811,248.311,252.307,254.656,258.157,262.153,266.149,270.649,275.149,279.649,281.998,288.001,293.005,298.009" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.39,0.67,0.72,0.25,0.72,0.72,0.72,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.28,0.44,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.28,0.28,0.78,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.67,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(18%) JCV DNA was undetectable at the time of the second CSF </text>
   <text y="422.917" x="62.362,65.863,69.859,76.861,81.361,83.863,86.365,90.865,95.365,97.615,99.865,102.358,105.355,109.855,112.105,114.598,119.098,123.598,126.1,130.6,135.1,137.35,139.843,144.343,148.339,150.841,153.343,157.339,161.839,164.341,167.842,170.092,172.585,175.582,180.082,184.582,192.079,195.076,197.326,199.576,202.069,206.569,211.069,217.567,221.563,226.063,230.059,232.696,234.946,237.196,239.689,243.19,249.193,255.529,257.779,260.272,266.77,273.268,279.271,281.521,284.014,290.512,294.508,298.009" svgx:width="0.39,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.83,0.33,0.25,0.25,0.55,0.5,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.72,0.72,0.72,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sampling. In 26/65 patients (40%), however, JCV DNA was </text>
   <text y="433.915" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,91.846,96.346,98.596,99.856,102.358,106.858,109.108,110.368,112.87,117.37,121.366,123.616,124.876,127.873,131.869,136.369,140.365,144.361,146.863,149.113,150.373,156.376,161.38,165.664,167.914,170.164,171.424,174.421,178.921,181.171,182.431,189.433,193.933,197.434,199.936,202.186,203.446,207.946,210.943,213.193,214.453,216.955,221.455,225.451,228.952,232.948,235.198,236.458,240.454,244.45,247.951,251.947,255.448,257.698,259.948,261.199,264.7,270.703,277.039,279.289,280.549,284.545,289.045,293.545,298.045" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.5,0.44,0.44,0.28,0.25,0.55,0.67,0.56,0.56,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.78,0.5,0.39,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased in the repeat CSF. In most of these cases, JCV copy </text>
   <text y="444.913" x="62.362,66.862,71.362,78.364,82.864,86.86,89.857,93.358,96.193,100.189,102.691,105.526,108.028,112.024,116.02,119.521,122.023,124.858,129.358,133.858,138.358,142.858,145.36,149.356,153.856,156.691,160.687,165.187,169.687,172.522,175.024,179.524,183.52,186.517,190.513,194.509,198.01,202.006,206.506,209.341,211.843,216.343,219.178,223.174,226.675,229.51,236.512,241.012,245.008,249.508,252.343,256.339,259.84,262.675,267.175,271.675,276.175,280.675,288.172,291.007,293.509,298.009" svgx:width="0.5,0.5,0.78,0.5,0.44,0.33,0.39,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.39,0.25,0.78,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.5,0.5,0.5,0.5,0.83,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">numbers at least doubled and increased to as much as 4000% in </text>
   <text y="455.911" x="62.362,65.863,70.363,77.365,81.361,83.791,87.787,91.783,95.284,99.28,102.781,105.031,107.461,113.959,117.955,124.957,129.457,133.957,136.954,140.95,145.45,149.95,152.452,156.448,158.878,162.874,167.374,171.874,174.304,178.3,180.802,183.304,187.804,190.306,194.302,198.298,200.8,203.23,207.226,211.726,215.722,218.719,222.715,226.711,229.213,233.209,236.206,238.708,242.209,244.711,247.213,251.209,254.71,257.14,261.64,264.142,268.642,271.072,275.572,280.072,282.574,285.004,289.504,292.006,295.003" svgx:width="0.39,0.5,0.78,0.44,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.72,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.39,0.28,0.28,0.44,0.39,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.28,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">some cases. Demographic and clinical characteristics did not dif-</text>
   <text y="466.909" x="62.362,65.359,69.355,72.352,74.602,75.628,79.129,81.631,86.131,90.631,93.133,96.13,98.632,102.628,106.624,111.124,113.626,116.128,120.628,122.878,123.904,128.404,132.4,134.902,141.4,145.396,149.392,153.892,156.142,157.168,161.668,165.664,168.166,170.668,174.664,179.164,181.666,185.167,187.417,188.443,194.941,197.443,199.945,204.445,206.695,207.721,210.223,214.723,218.719,221.716,225.712,229.708,233.209,237.205,239.455,240.481,244.477,248.977,253.477,255.727,256.753,261.253,265.249,269.245,272.242,276.238,280.234,283.735,287.731,289.981,291.007,293.509,298.009" svgx:width="0.33,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fer significantly between patients with increase and decrease in </text>
   <text y="477.907" x="62.362,64.864,69.364,73.36,75.862,78.859,81.109,82.567,85.564,89.56,94.06,98.056,102.052,104.554,106.804,108.262,114.265,119.269,124.273,126.523,127.981,131.977,136.477,140.473,144.973,147.223,148.681,155.179,157.681,160.183,164.683,166.933,168.391,172.387,176.887,179.389,183.889,187.885,192.385,196.381,200.377,202.627,204.085,208.585,211.582,213.832,215.29,217.792,224.794,231.796,236.296,240.796,244.792,247.042,248.5,251.497,255.493,259.489,263.989,268.489,271.99,274.492,276.994,279.496,283.996,286.498,289.0,293.5,298.0" svgx:width="0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.33,0.44,0.5,0.44,0.44,0.28,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.44,0.5,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">their repeat CSF even with evidence of immune reconstitution </text>
   <text y="488.905" x="62.362,65.863,70.363,74.863,79.363,82.36,86.86,93.862,97.858,100.108,103.105,106.102,112.105,115.102,120.106,123.103" svgx:width="0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.33,0.33,0.67,0.33,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">syndrome (IRIS).</text>
   <text y="499.903" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="499.903" x="115.282,120.286,124.282,127.279,130.78,133.282,136.783,139.285,143.281,147.781,151.777,155.773,158.023,159.184,163.684,166.681,168.931,170.092,173.593,179.596,185.932,188.182,189.343,191.845,196.345,198.595,199.756,202.258,206.758,210.754,213.004,214.165,220.168,225.172,230.176,232.426,233.587,236.089,239.59,241.84,243.001,246.502,250.498,254.494,258.994,261.244,262.405,264.907,269.407,271.657,272.818,276.814,279.064,280.225,282.727,286.723,289.558,294.058,298.054" svgx:width="0.56,0.44,0.33,0.39,0.28,0.39,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.28,0.39,0.25,0.55,0.39,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Persistence of JCV in the CSF is seen in a large </text>
   <text y="510.901" x="62.362,66.862,70.858,73.855,77.851,81.847,86.347,88.849,92.845,97.345,101.341,103.834,108.334,111.331,113.824,121.825,126.829,129.322,133.822,137.818,140.32,142.822,146.818,151.318,153.82,157.321,159.814,166.312,168.814,171.316,175.816,178.309,183.313,191.314,196.813,199.063,201.394,209.89,214.39,216.892,220.888,225.388,227.881,230.878,234.874,238.87,241.372,245.872,248.869,252.37,254.863,258.859,261.694,264.691,268.687,272.683,275.185,277.678,281.674,284.176,288.172,292.168,295.021" svgx:width="0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.89,0.61,0.25,0.25,0.94,0.5,0.28,0.44,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.44,0.28,0.44,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">percentage of MS patients with PML. Which factors affect clear-</text>
   <text y="521.899" x="62.362,66.358,70.858,74.854,78.85,81.1,85.6,88.597,90.847,94.348,100.351,106.687,108.937,111.934,114.931,119.431,126.433,128.683,134.686,139.69,144.694,146.944,151.444,155.44,159.436,163.936,167.437,169.687,172.684,177.184,180.181,182.683,187.183,191.179,194.176,196.426,198.928,203.428,207.928,211.924,215.425,217.927,220.429,224.929,228.925,231.427,233.929,238.429,242.929" svgx:width="0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25,0.33,0.33,0.5,0.78,0.25,0.67,0.56,0.56,0.25,0.5,0.44,0.44,0.5,0.39,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ance of JCV from CSF needs further investigation.</text>
   <text y="554.902" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P867</text>
   <text y="565.9" x="62.362,68.365,72.865,77.869,82.369,85.366,88.363,92.359,96.355,103.852,106.102,109.603,114.103,117.1,121.096,124.093,128.593,130.843,135.343,138.34,140.59,144.586,147.088,150.085,155.089,159.589,162.091,169.588,174.088,179.092,181.342,183.844,188.848,191.098,199.594,204.598,206.848,211.348,216.352,221.356,223.606,228.106,231.103,236.107,240.103,244.099" svgx:width="0.67,0.5,0.56,0.5,0.33,0.33,0.44,0.44,0.83,0.25,0.39,0.5,0.33,0.44,0.33,0.5,0.25,0.5,0.33,0.25,0.44,0.28,0.33,0.56,0.5,0.28,0.83,0.5,0.56,0.25,0.28,0.56,0.25,0.94,0.56,0.25,0.5,0.56,0.56,0.25,0.5,0.33,0.56,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Long-term safety of rituximab in MS and other </text>
   <text y="576.898" x="62.362,66.862,71.866,74.863,79.363,81.865,89.362,96.859,101.863,106.867,110.863,113.113,118.117,120.619,124.12,128.62,132.616,137.62,141.616,145.612" svgx:width="0.5,0.56,0.33,0.5,0.28,0.83,0.83,0.56,0.56,0.44,0.25,0.56,0.28,0.39,0.5,0.44,0.56,0.44,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">autoimmune disorders</text>
   <text y="587.896" x="62.362,67.861,70.111,76.114,80.11,83.107,87.607,90.109,92.611,96.112,100.108" svgx:width="0.61,0.25,0.67,0.44,0.33,0.5,0.28,0.28,0.39,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">E Bernitsas</text>
   <text y="585.439" x="103.609" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="587.959" x="106.534,108.784,111.034,116.038,118.288,124.291,128.287" svgx:width="0.25,0.25,0.56,0.25,0.67,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Bao</text>
   <text y="585.439" x="132.786" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="587.959" x="135.711,137.961,140.211,145.215,147.465,152.469,155.466,157.968,164.466,168.462,171.963,174.465,178.461,182.961" svgx:width="0.25,0.25,0.56,0.25,0.56,0.33,0.28,0.72,0.44,0.39,0.28,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Sriwastava</text>
   <text y="585.439" x="186.957" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="587.959" x="189.882,192.132,194.382,200.88,203.13,211.131,215.127,222.129,226.629" svgx:width="0.25,0.25,0.72,0.25,0.89,0.44,0.78,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Memon</text>
   <text y="585.439" x="231.128" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="587.959" x="234.053,236.303,238.553,245.051,247.301,252.8,256.301,260.297,262.799,265.301" svgx:width="0.25,0.25,0.72,0.25,0.61,0.39,0.44,0.28,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Tselis</text>
   <text y="585.439" x="268.802" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="587.959" x="271.727,273.977,276.227,282.725" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, O </text>
   <text y="598.957" x="62.36,68.858,73.358,77.354" svgx:width="0.72,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Khan</text>
   <text y="596.439" x="81.856" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="607.437" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="609.959" x="65.287,72.784,77.284,81.28,85.78,89.776,92.026,96.526,99.028,103.528,106.03,110.026,112.276,118.774,123.274,125.776,129.772,133.768,137.269,140.77,143.272,145.774,149.77,152.02,154.27,160.768,164.764,167.266,170.767,175.267,177.769,180.271,182.521,184.771,192.268,195.265,197.515,199.765,206.263,210.763,213.265,215.767,219.763,224.263,226.513,231.013,233.515,238.015,240.517,244.513" svgx:width="0.83,0.5,0.44,0.5,0.44,0.25,0.5,0.28,0.5,0.28,0.44,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.72,0.44,0.28,0.39,0.5,0.28,0.28,0.25,0.25,0.83,0.33,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Wayne State University, Detroit, MI, United States</text>
   <text y="636.959" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="636.959" x="115.894,121.897,124.399,126.901,131.401,135.901,138.403,145.405,149.401,153.901,156.151,157.087,159.589,163.09,165.34,166.276,170.272,174.772,177.022,177.958,181.954,186.454,188.956,191.458,194.455,200.458,206.956,211.456,215.956,218.206,219.142,226.144,230.644,235.144,239.644,243.64,246.142,250.642,255.142,259.138,261.64,263.89,264.826,268.822,273.322,275.824,278.326,282.826,287.326,291.826,295.741,297.991" svgx:width="0.67,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.67,0.72,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Rituximab is an anti-CD20 monoclonal antibody, </text>
   <text y="647.957" x="62.362,66.862,70.363,74.359,78.859,81.109,82.801,87.301,90.136,93.133,96.13,98.632,102.628,107.128,111.124,113.626,115.876,117.568,120.07,124.57,126.82,128.512,133.012,137.008,140.005,142.507,147.007,151.507,155.008,157.258,158.95,162.946,167.446,169.948,174.448,176.95,183.952,190.954,195.454,199.954,203.95,206.2,207.892,212.392,214.894,218.395,222.895,225.892,230.392,234.388,237.385,240.886,243.136,244.828,247.33,251.83,255.826,258.328,262.828,267.328,269.83,274.33,278.83,281.08,282.772,290.773,295.777,298.027" svgx:width="0.5,0.39,0.44,0.5,0.25,0.55,0.5,0.33,0.33,0.33,0.28,0.44,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">used off-label in various autoimmune disorders including MS, </text>
   <text y="658.955" x="62.362,68.86,76.861,83.359,85.609,88.237,92.233,96.733,101.233,103.87,110.872,115.372,119.368,122.869,125.371,129.871,133.867,138.367,140.869,144.865,147.493,151.993,154.99,158.986,163.486,165.988,169.489,171.739,174.367,179.866,183.862,186.859,189.361,193.861,196.489,199.99,202.492,206.488,210.988,214.984,217.621,221.617,224.119,226.621,231.121,233.623,237.619,241.615,244.117,246.745,249.247,252.244,254.746,258.742,261.244,264.745,267.373,271.369,275.869,280.369,283.006,286.507,290.503,295.003" svgx:width="0.72,0.89,0.72,0.25,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.44,0.39,0.28,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.39,0.25,0.25,0.61,0.44,0.33,0.28,0.5,0.25,0.39,0.28,0.44,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO, and myasthenia gravis. Early stage clinical trials and sev-</text>
   <text y="669.953" x="62.362,66.358,69.355,73.351,75.853,78.103,79.462,83.458,87.454,90.955,94.951,97.201,98.56,102.061,106.057,109.054,111.556,115.552,119.053,121.303,122.662,127.162,131.158,135.658,139.654,141.904,143.263,146.764,151.264,155.764,162.262,166.762,169.012,170.371,173.368,177.364,184.366,188.362,191.359,195.859,199.855,204.355,206.857,210.853,213.103,214.462,218.458,221.293,224.29,226.792,230.788,234.784,238.78,242.695,244.945,247.195,248.554,255.052,259.552,266.05,270.046,274.546,278.542,281.179,283.429,285.679,287.038,289.54,294.04,298.036" svgx:width="0.44,0.33,0.44,0.28,0.25,0.55,0.44,0.44,0.39,0.44,0.25,0.55,0.39,0.44,0.33,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.72,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.55,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">eral case series have shown remarkable efficacy. However, the </text>
   <text y="680.951" x="62.362,64.864,69.364,73.864,78.364,81.361,83.863,87.859,90.856,97.858,100.108,103.528,107.029,111.025,114.022,118.018,120.52,125.02,127.27,130.69,135.19,138.187,140.437,143.857,147.358,151.858,155.359,157.861,161.857,164.359,168.859,172.855,177.355,179.605,183.025,187.525,191.521,194.518,197.02,201.52,206.02,210.016,213.013,217.009,219.511,221.761,225.181,231.184,234.181,238.177,242.173,244.675,247.177,249.427,252.847,257.347,261.343,265.843,268.345,272.341,274.843,277.345,281.845,286.345,288.595,292.015,294.517,298.018" svgx:width="0.28,0.5,0.5,0.5,0.33,0.28,0.44,0.33,0.78,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.39,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">long-term safety of sustained peripheral B-cell depletion is </text>
   <text y="691.949" x="62.362,66.862,71.362,75.862,80.362,84.862,91.36,95.86" svgx:width="0.5,0.5,0.5,0.5,0.5,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">unknown.</text>
   <text y="702.947" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="702.947" x="108.406,116.182,120.178,122.734,126.73,131.23,135.226,142.228,144.73,149.23,153.226,157.726,160.282,162.784,167.284,171.28,173.836,176.338,180.838,184.834,187.336,191.836,195.832,200.332,204.328,208.324,210.88,215.38,218.377,220.933,223.435,227.935,230.932,234.928,238.924,241.426,243.928,248.428,252.928,256.429,258.985,262.981,267.481,271.981,274.537,281.539,285.535,288.037,290.539,295.039" svgx:width="0.94,0.44,0.25,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We examined the incidence of infections and malig-</text>
   <text y="713.945" x="62.362,66.862,70.858,75.358,79.354,81.856,85.852,89.353,91.315,93.817,98.317,100.279,104.779,108.775,111.277,113.779,117.775,122.275,124.777,128.278,130.24,136.738,141.238,145.738,147.7,150.697,154.693,158.689,162.685,165.187,169.687,173.683,178.183,180.145,184.141,188.641,193.141,195.643,198.145,202.645,207.145,211.645,216.145,219.646,221.608,224.605,227.107,229.609,234.109,238.609,241.111,248.113,252.109,256.609,258.571,261.073,265.573,269.569,272.566,276.562,281.062,285.562,287.524,290.521,295.021,298.018" svgx:width="0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.39,0.25,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nancies in patients who received continuous rituximab therapy for </text>
   <text y="724.943" x="62.362,66.358,68.86,71.11,73.612,77.608,81.604,85.105,87.607,89.857,94.357,96.607,101.107,105.103,109.099,112.096,115.597" svgx:width="0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">at least 3 years.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 435.300 L340.260 435.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="77.103" x="348.473,353.972,358.472,360.974,364.475,366.437,372.935,376.931,380.432,382.394,386.39,388.352,391.349,395.345,397.847,400.844,405.344,408.845,413.345,417.341,421.337,423.839,426.341,430.841,434.837,436.799,440.3,442.802,447.302,451.802,456.302,458.264,462.26,466.76,470.756,477.758,480.26,484.76,487.262,491.762,496.262,498.224,500.726,505.226,509.222,511.184,513.686,518.186,522.182,524.684,529.184,533.18,537.68,541.676,545.672" svgx:width="0.61,0.5,0.28,0.39,0.25,0.72,0.44,0.39,0.25,0.44,0.25,0.33,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.44,0.78,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">This was a retrospective study examining the incidence </text>
   <text y="88.101" x="310.016,314.516,317.513,319.763,322.004,324.506,329.006,332.003,335.999,339.995,342.497,344.999,349.499,353.999,357.5,359.75,361.991,364.493,368.993,372.989,375.491,379.991,384.491,386.993,391.493,395.993,398.243,400.484,403.985,407.981,410.978,413.48,417.98,422.48,425.981,428.231,430.472,432.974,437.474,440.471,444.467,448.463,450.965,453.467,457.967,462.467,465.968,468.218,470.468,472.709,477.209,481.709,486.209,490.709,493.706,496.208,500.708,505.208,507.71,511.211,513.713,516.215,520.211,522.461,524.702,527.204,531.704,534.701,538.697,542.693" svgx:width="0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.28,0.5,0.5,0.28,0.39,0.28,0.28,0.44,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of infections including serious infections, opportunistic infec-</text>
   <text y="99.099" x="310.016,312.518,315.02,319.52,324.02,327.521,329.771,332.039,336.035,340.535,345.035,347.303,354.305,358.301,360.803,363.305,367.805,372.305,376.301,380.801,384.797,387.299,391.295,394.796,397.064,399.566,404.066,406.334,410.834,414.83,417.332,419.834,423.83,428.33,430.832,434.333,436.601,443.099,447.599,452.099,454.367,457.364,461.36,465.356,469.352,471.854,476.354,480.35,484.85,487.118,491.618,493.886,500.888,505.388,509.888,512.39,516.89,519.392,523.892,526.16,528.662,533.162,535.664,538.661,542.657" svgx:width="0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.28,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tions, and malignancies in patients who received 6 monthly intra-</text>
   <text y="110.097" x="310.016,314.516,318.512,323.012,327.512,332.012,335.513,337.763,338.591,342.587,347.087,351.083,353.585,357.581,361.082,363.332,364.16,368.66,371.657,373.907,374.735,377.732,380.234,382.736,387.236,391.736,394.238,401.24,405.236,409.736,411.986,412.814,415.316,419.816,422.813,427.313,430.814,433.316,437.816,442.316,445.817,448.067,448.895,452.891,457.391,461.891,464.393,466.895,471.395,475.895,480.395,484.895,488.396,490.898,495.398,497.648,498.476,501.473,505.973,508.97,511.22,512.048,516.044,518.546,520.796,521.624,524.126,528.122,532.118,535.619,538.121,540.371,541.199,545.699" svgx:width="0.5,0.44,0.5,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.39,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.44,0.44,0.39,0.28,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">venous cycles of rituximab infusions continuously for at least 3 </text>
   <text y="121.095" x="310.016,314.516,318.512,322.508,325.505,329.006" svgx:width="0.5,0.44,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">years.</text>
   <text y="132.093" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="132.093" x="344.972,349.472,353.972,356.222,357.932,362.432,366.428,368.93,371.432,375.428,379.928,382.43,385.931,388.181,389.891,392.888,399.89,403.886,407.882,412.382,414.632,416.342,420.338,424.838,428.834,431.084,432.794,437.294,441.794,444.044,445.754,450.254,454.25,458.246,461.243,464.744,467.741,469.991,471.701,474.698,478.694,482.69,486.686,489.188,493.688,497.684,502.184,504.434,506.144,510.14,514.64,519.14,521.642,524.144,528.644,533.144,537.644,542.144,545.645" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.33,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">23 patients (mean age 40 years) received continuous </text>
   <text y="143.091" x="310.016,314.516,317.513,324.515,329.015,333.515,336.017,340.517,343.019,347.519,349.787,352.784,355.286,357.788,362.288,366.788,369.29,376.292,380.288,384.788,387.056,389.558,394.058,397.055,401.555,405.056,407.558,412.058,416.558,420.059,422.327,425.324,429.824,432.821,435.089,439.085,441.353,445.853,449.849,452.846,455.348,459.848,464.348,466.616,469.613,473.609,478.109,482.609,485.111,489.611,494.111,496.379,499.376,502.373,506.873,513.875,516.143,520.643,525.143,527.411,529.913,534.413,536.681,541.181,545.681" svgx:width="0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.39,0.25,0.33,0.5,0.33,0.25,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">6-monthly rituximab infusions for a period ranging from 36 to 72 </text>
   <text y="154.089" x="310.016,317.018,321.518,326.018,328.52,333.02,336.521,338.771,339.635,342.632,349.634,353.63,357.626,362.126,364.628,366.878,367.742,372.242,376.742,378.992,383.492,385.742,386.606,393.608,398.108,402.608,405.11,409.61,413.111,416.108,418.358,420.608,421.472,427.475,433.973,438.473,442.973,445.223,446.087,450.083,454.583,459.083,463.583,466.085,469.586,471.836,472.7,479.198,483.194,486.191,490.187,492.437,493.301,497.801,500.051,500.915,504.911,507.413,509.663,510.527,517.529,522.029,526.529,529.031,533.531,535.781,536.645,541.145,545.645" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.33,0.78,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.33,0.25,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months (mean: 51.1 months). CD19 counts were 0 at month 12 </text>
   <text y="165.087" x="310.016,314.012,318.512,323.012,325.262,326.882,329.879,333.875,340.877,344.873,347.375,351.875,355.871,360.371,362.621,364.241,368.741,370.991,372.611,376.607,379.109,381.359,382.979,385.481,389.477,392.978,395.48,397.73,399.35,403.85,408.35,411.851,415.847,418.844,423.344,427.34,429.842,432.344,436.844,441.344,443.594,445.844,447.455,453.458,455.96,458.462,462.962,467.462,469.964,476.966,480.962,485.462,487.712,489.332,491.834,494.831,498.827,502.823,505.325,509.321,513.821,516.071,517.691,522.191,526.187,528.689,531.191,535.187,539.687,542.189,545.69" svgx:width="0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.44,0.39,0.28,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.67,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and remained 0 at last observation. Rituximab treated patients </text>
   <text y="176.085" x="310.016,312.518,317.018,321.014,323.516,328.016,332.516,336.512,341.012,343.073,349.571,357.572,364.07,366.131,369.128,373.628,378.704,383.204,387.704,390.701,392.951,395.012,403.013,408.017,410.078,413.075,417.575,422.651,427.151,430.148,432.398,434.459,438.455,442.955,447.455,449.021,455.519,460.019,462.521,465.023,468.02,476.021,480.521,485.525,492.023,494.084,498.08,502.58,505.082,507.584,512.084,516.584,521.084,525.584,527.645,532.145,536.645,540.146,542.648" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.72,0.89,0.72,0.25,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.89,0.56,0.25,0.33,0.5,0.56,0.5,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.72,0.5,0.28,0.28,0.33,0.89,0.5,0.56,0.72,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">included NMO (n=15), MS (n=5), and Anti-MuSK antibody posi-</text>
   <text y="187.083" x="310.016,312.518,315.02,319.52,323.516,325.766,327.44,335.441,341.939,344.189,345.872,348.869,353.369,358.445,362.945,365.942,368.192,370.442,372.116,377.12,381.62,384.617,387.119,391.619,394.616,398.612,401.114,405.614,410.114,412.616,414.866,416.54,424.541,429.545,431.795,433.478,437.978,441.974,444.476,446.978,450.974,455.474,457.976,461.477,463.727,465.401,468.398,475.4,479.396,483.392,487.892,490.142,491.816,495.812,500.312,504.308,506.81,509.06,510.743,515.243,519.743,521.993,523.667,528.167,532.163,536.159,539.156,542.657,545.654" svgx:width="0.28,0.28,0.5,0.44,0.25,0.55,0.89,0.72,0.25,0.55,0.33,0.5,0.56,0.5,0.33,0.25,0.25,0.55,0.56,0.5,0.33,0.28,0.5,0.33,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tive MG (n=3). Forty-eight MS patients (mean age: 41 years) </text>
   <text y="198.081" x="310.016,313.013,317.009,321.005,325.001,327.503,332.003,334.505,339.005,343.505,345.755,346.754,349.256,353.756,356.258,360.254,363.251,366.248,370.244,373.241,377.741,382.241,384.491,385.49,389.99,393.986,396.488,400.484,402.734,403.733,408.233,411.23,413.48,414.479,418.979,421.481,425.477,427.979,430.481,433.478,437.474,444.476,448.472,451.469,453.719,454.718,458.714,462.71,466.706,469.208,473.204,475.706,479.702,481.952,482.951,485.453,489.953,493.949,496.946,500.942,505.442,509.942,512.192,513.191,517.691,522.191,525.692,529.688,532.685,537.185,541.181,545.681" svgx:width="0.33,0.44,0.44,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25,0.55,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">receiving interferon beta or glatiramer acetate therapy observed </text>
   <text y="209.079" x="310.016,313.013,317.513,320.51,322.769,327.269,329.528,334.028,338.024,342.02,345.017,348.518,350.768,353.027,356.528,360.524,363.521,368.021,372.017,376.517,378.776,382.772,386.273,388.532,392.528,397.028,401.528,404.03,407.027,411.527,414.029,416.288,420.788,423.785,428.285,432.785,437.285,439.535,441.632,447.131,451.631,455.627,458.624,462.62,464.879,471.377,475.373,478.874,481.133,485.633,490.133,492.392,495.893,498.395,502.895,507.395,509.897,512.894,515.396,519.392,523.388,527.888,530.39,532.649,537.149,539.651,542.648" svgx:width="0.33,0.5,0.33,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for 3 years, served as control group. There was no significant dif-</text>
   <text y="220.077" x="310.016,313.013,317.009,320.006,324.002,328.502,332.498,336.494,338.744,340.103,342.605,347.105,349.355,350.714,353.216,357.716,361.712,363.962,365.321,367.823,372.323,376.319,378.821,383.321,387.317,391.817,395.813,399.809,402.059,403.418,407.918,410.915,413.165,414.524,417.026,421.526,424.523,428.519,432.515,435.017,437.519,442.019,446.519,450.02,452.27,453.629,458.129,462.125,464.627,471.125,475.121,479.117,483.617,485.867,487.226,489.728,494.228,498.224,500.474,501.833,504.335,510.833,515.333,517.583,518.942,523.442,526.439,530.939,535.439,539.939,543.44,545.69" svgx:width="0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ference in the incidence of infections between the two groups. </text>
   <text y="231.075" x="310.016,315.02,319.52,324.02,327.017,328.826,332.327,336.323,339.32,341.822,346.322,350.822,354.323,356.132,358.634,363.134,366.131,370.127,374.123,376.625,379.127,383.627,388.127,391.628,393.437,396.434,399.431,403.427,407.927,412.427,414.929,417.926,420.428,424.928,429.428,431.237,435.737,440.237,443.738,448.238,450.74,453.242,457.238,459.74,462.242,466.238,470.234,472.736,475.238,479.738,484.238,487.235,489.044,491.546,496.046,497.855,500.357,504.857,508.853,510.662,513.659,516.161,518.663,523.163,527.663,530.165,537.167,541.163,545.663" svgx:width="0.56,0.5,0.5,0.33,0.25,0.39,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.33,0.33,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.25,0.5,0.5,0.39,0.5,0.28,0.28,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Four serious infections (requiring hospitalization) in the rituximab </text>
   <text y="242.073" x="310.016,314.012,318.512,323.012,324.947,329.447,331.382,333.884,338.384,340.319,342.821,347.321,351.317,353.252,357.248,361.748,366.248,368.75,371.747,376.247,378.749,380.684,385.184,388.181,392.681,397.181,401.681,403.616,410.114,414.11,417.107,421.103,423.038,427.538,432.038,435.539,439.535,442.532,447.032,451.028,455.528,457.463,460.46,464.96,470.036,474.536,478.037,481.034,483.284,485.219,491.717,496.217,498.152,502.652,507.152,511.652,516.152,519.149,521.651,526.151,530.651,533.153,536.654,539.156,541.658,545.654" svgx:width="0.44,0.5,0.5,0.25,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.33,0.5,0.56,0.5,0.39,0.33,0.25,0.25,0.72,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.28,0.5,0.5,0.28,0.39,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 7 in the control group were observed (p=ns). No opportunistic </text>
   <text y="253.071" x="310.016,312.518,317.018,320.015,324.011,328.007,330.509,333.011,337.511,342.011,345.512,347.474,351.974,354.971,356.942,363.944,367.94,370.442,372.944,377.444,381.944,385.94,390.44,394.436,398.936,400.898,407.396,411.392,414.389,418.385,420.347,424.847,429.347,432.848,436.844,439.841,444.341,448.337,452.837,454.799,457.301,461.801,463.772,467.768,470.27,472.772,477.272,481.268,484.265,486.227,490.727,493.724,498.224,502.724,507.224,509.186,513.686,518.186,521.183,523.685,528.185,532.685,534.656,537.158,541.658,545.654" svgx:width="0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">infections or malignancy were observed in either group during the </text>
   <text y="264.069" x="310.016,314.516,319.016,322.517,326.513,329.51,334.01,338.006,340.508,343.01,347.51,352.01,354.26,356.303,360.803,364.799,367.796,370.298,374.798,379.298,381.548,383.591,386.588,390.584,395.084,399.584,402.086,406.586,411.086,413.336,415.379,419.879,424.379,426.629,428.672,431.174,435.674,437.924,439.967,444.467,448.967,451.217,453.26,460.262,464.762,469.262,471.764,476.264,479.765,482.015,484.058,486.56,491.06,493.31,495.353,497.855,502.355,506.351,508.601,510.644,513.641,516.143,518.645,523.145,527.645,530.147,537.149,541.145,545.645" svgx:width="0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">observation period ranging up to 72 months in the rituximab </text>
   <text y="275.067" x="310.016,314.516,317.513,322.013,326.513,331.013,333.236,337.232,341.732,346.232,348.455,352.955,357.455,359.678,366.68,371.18,375.68,378.182,382.682,386.183,388.406,390.908,395.408,397.631,400.133,404.633,408.629,410.852,414.848,419.348,423.848,426.35,429.347,433.847,436.349,438.572,443.072,446.069,450.569,455.069,459.569,461.819,464.042,469.046,472.043,476.039,478.262,482.258,486.758,491.258,493.481,497.981,502.481,505.982,508.484,510.707,513.704,516.206,518.708,523.208,527.708,530.21,537.212,541.208,545.708" svgx:width="0.5,0.33,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.56,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.25,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">group and 36 months in the control group. Pre and post rituximab </text>
   <text y="286.065" x="310.016,313.517,318.017,322.517,329.015,333.011,337.511,339.761,341.327,344.324,348.32,355.322,359.318,362.315,366.815,370.811,375.311,377.813,381.809,384.059,385.625,388.622,392.618,397.118,401.618,405.614,408.116,410.618,415.118,419.618,421.868,423.434,425.936,430.436,432.686,434.252,438.752,441.254,444.755,448.751,452.747,456.248,460.244,462.494,464.06,468.056,472.052,474.554,477.056,481.556,484.058,486.56,490.475,492.725,494.975,496.541,502.04,504.875,507.872,510.374,514.37,518.366,522.362,526.862,529.112,530.678,535.178,539.174,541.676,545.672" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.55,0.61,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed remarkable reduction in disease activity. Efficacy data </text>
   <text y="297.063" x="310.016,316.514,319.016,321.518,324.02,326.27,330.266,332.768,336.269,340.769,343.019,347.519,351.515,353.765,358.265,361.262,365.258,368.759,372.755,377.255,379.757,383.753,388.253" svgx:width="0.72,0.28,0.28,0.28,0.25,0.44,0.28,0.39,0.5,0.25,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">will also be presented.</text>
   <text y="308.061" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="308.061" x="361.451,367.949,370.451,372.953,377.453,381.953,386.453,390.953,395.453,397.379,401.879,404.876,408.872,411.374,413.876,420.878,423.38,427.88,431.876,434.873,438.788,441.038,442.964,447.464,451.964,454.961,456.887,461.387,465.887,469.388,473.384,476.381,480.881,484.877,487.379,489.881,494.381,498.881,502.382,504.308,508.808,513.308,515.234,519.734,524.234,526.736,528.662,531.164,535.664,540.164,542.666" svgx:width="0.72,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.33,0.44,0.28,0.28,0.78,0.28,0.5,0.44,0.33,0.5,0.25,0.25,0.5,0.5,0.33,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.5,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Although preliminary, our observations do not indi-</text>
   <text y="319.059" x="310.016,314.012,318.008,320.51,324.506,326.756,328.655,332.651,337.151,339.401,341.3,343.802,348.302,352.298,355.295,359.291,363.287,366.788,370.784,375.284,377.534,379.433,382.43,384.932,388.433,392.933,395.183,397.082,401.582,404.579,406.829,408.728,411.23,415.73,418.727,422.723,426.719,429.221,431.723,436.223,440.723,444.224,446.474,448.373,454.871,457.373,459.875,464.375,466.625,468.524,473.024,476.021,480.521,483.023,487.523,492.023,496.523,500.519,505.019,507.269,509.168,513.668,517.664,520.661,523.163,527.663,532.163,536.159,539.156,543.152,545.654" svgx:width="0.44,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cate an increased risk of infections with prolonged peripheral </text>
   <text y="330.057" x="310.016,316.019,319.016,323.012,327.008,329.51,332.012,334.595,339.095,343.091,347.591,350.093,354.089,356.591,359.093,363.593,368.093,370.676,373.178,377.678,380.261,384.761,388.757,391.259,393.761,397.757,402.257,404.759,408.26,410.843,417.341,421.841,426.341,428.924,431.921,435.917,439.913,443.909,446.411,450.911,454.907,459.407,461.99,464.987,467.489,469.991,474.491,478.991,481.493,488.495,492.491,496.991,499.574,502.076,506.576,509.573,514.073,517.574,520.076,524.576,529.076,532.577,535.16,538.157,542.657,545.654" svgx:width="0.67,0.33,0.44,0.44,0.28,0.28,0.25,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.33,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.39,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B-cell depletion in patients who received rituximab infusions for </text>
   <text y="341.055" x="310.016,314.516,319.016,320.942,323.444,327.944,329.87,334.37,336.296,340.796,344.792,348.788,351.785,355.286,357.212,361.208,365.708,370.208,372.71,375.212,379.712,384.212,388.712,393.212,396.713,399.215,403.13,405.38,407.144,415.64,420.14,422.642,425.144,429.14,431.066,435.062,439.562,443.558,448.058,452.558,455.555,459.551,464.051,466.553,471.053,475.553,477.803,479.729,482.231,486.731,490.727,494.228,498.224,500.15,504.65,509.15,512.651,516.647,519.644,524.144,528.14,530.642,533.144,537.644,542.144,545.645" svgx:width="0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.39,0.28,0.5,0.25,0.25,0.94,0.5,0.28,0.28,0.44,0.25,0.44,0.5,0.44,0.5,0.5,0.33,0.44,0.5,0.28,0.5,0.5,0.25,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">up to 6 years continuously. While encouraging, these observations </text>
   <text y="352.053" x="310.016,317.018,321.518,325.019,327.521,329.834,334.334,338.33,340.643,345.143,347.645,351.641,358.139,362.135,366.635,368.948,375.446,377.948,380.45,384.95,387.263,391.259,395.255,399.755,402.257,404.759,409.259,413.759,416.072,420.572,425.072,429.068,431.381,433.883,438.383,440.696,443.198,447.698,451.694,454.007,457.508,464.51,468.506,471.008,473.51,475.823,480.323,484.823,491.825,496.325,500.321,503.318,505.631,510.131,513.128,515.441,519.941,523.937,526.439,528.941,532.937,537.437,539.939,543.44,545.69" svgx:width="0.78,0.5,0.39,0.28,0.25,0.5,0.44,0.25,0.5,0.28,0.44,0.72,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.78,0.44,0.28,0.28,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">must be viewed with caution due to the small number of patients. </text>
   <text y="363.051" x="310.016,315.515,319.511,322.346,326.846,330.842,333.839,336.089,339.59,342.092,346.592,351.092,353.594,357.59,361.091,363.341,367.337,370.334,374.33,376.58,383.078,387.074,390.071,393.068,397.064,401.564,404.066,408.062,412.562,414.812,417.314,421.814,424.064,428.06,432.56,437.06,440.057,442.559,445.556,452.558,454.808,457.31,461.81,465.806,469.307,473.303,475.553,478.55,481.052,485.552,490.052,492.554,497.054,501.554,505.055" svgx:width="0.61,0.44,0.33,0.5,0.44,0.33,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.33,0.44,0.25,0.72,0.44,0.33,0.33,0.44,0.5,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Larger studies are warranted to confirm these findings.</text>
   <text y="390.051" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P868</text>
   <text y="401.049" x="310.016,316.514,321.518,326.018,328.52,333.02,336.521,339.023,342.524,344.774,349.274,352.271,354.521,359.525,364.025,367.022,371.522,373.772,376.769,380.765,385.265,392.762,395.012,401.51,408.008,416.504,421.508,423.758,428.258,430.76,434.756,442.253,445.25,450.254,454.25,459.254,466.751,471.251,476.255,479.252,482.249,486.245,490.241,494.741,497.738,501.734,506.738" svgx:width="0.72,0.56,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.56,0.5,0.33,0.5,0.25,0.33,0.44,0.5,0.83,0.25,0.72,0.72,0.94,0.56,0.25,0.5,0.28,0.44,0.83,0.33,0.56,0.44,0.56,0.83,0.5,0.56,0.33,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Analysis of data from RRMS alemtuzumab-treated </text>
   <text y="412.047" x="310.016,315.02,319.52,322.517,325.019,329.015,334.019,337.016,340.517,342.767,345.269,350.273,352.523,355.52,360.524,364.52,366.77,370.766,373.268,375.77,380.774,383.276,387.272,391.772,394.274,396.524,401.528,405.524,410.024,414.524,418.52,423.02,430.517,432.767,435.764,440.264,442.514,446.51,451.01,455.51,458.012,463.016,467.516,470.513,474.509,476.759,479.261,484.265,488.261,490.763,495.767,499.763,504.767,508.763,512.759" svgx:width="0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.28,0.56,0.25,0.33,0.56,0.44,0.25,0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.56,0.44,0.5,0.5,0.44,0.5,0.83,0.25,0.33,0.5,0.25,0.44,0.5,0.5,0.28,0.56,0.5,0.33,0.44,0.25,0.28,0.56,0.44,0.28,0.56,0.44,0.56,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">patients in the clinical program to evaluate incidence </text>
   <text y="423.045" x="310.016,314.012,318.512,321.509,325.505,329.006,331.256,335.756,338.753,341.003,348.5,353.0,355.502,358.004,362.504,367.508,372.008,377.012,381.008" svgx:width="0.44,0.5,0.33,0.44,0.39,0.25,0.5,0.33,0.25,0.83,0.5,0.28,0.28,0.5,0.56,0.5,0.56,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">rates of malignancy</text>
   <text y="434.043" x="310.016,315.515,317.765,325.766,328.268,330.77,333.272,337.268" svgx:width="0.61,0.25,0.89,0.28,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T Miller</text>
   <text y="431.583" x="340.264" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="434.103" x="343.189,345.439,347.689,355.69,357.94,364.438,368.434,372.934,376.93" svgx:width="0.25,0.25,0.89,0.25,0.72,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Habek</text>
   <text y="431.583" x="381.43" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="434.103" x="384.355,386.605,388.855,395.353,401.851,404.101,412.102,416.098,419.095,423.595,428.095,430.597,433.099" svgx:width="0.25,0.25,0.72,0.72,0.25,0.89,0.44,0.33,0.5,0.5,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, DH Margolin</text>
   <text y="431.583" x="437.598" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="434.103" x="440.523,442.773,445.023,448.524,450.774,455.778,459.774,462.276,469.278,473.274" svgx:width="0.25,0.25,0.39,0.25,0.56,0.44,0.28,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Palmer</text>
   <text y="431.583" x="476.271" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="434.103" x="479.196,481.446,483.696,488.7,490.95,497.448,501.948,506.448,510.444,512.946" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.5,0.44,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Oyuela</text>
   <text y="431.583" x="516.942" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="434.103" x="519.867,522.117,524.367,528.867,533.367" svgx:width="0.25,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, on </text>
   <text y="445.101" x="310.014,314.514,318.51,323.01,327.006,329.508,332.505,334.755,339.255,342.252,344.502,347.004,351.504,355.5,357.75,363.753,370.251,378.252,386.253,391.257,395.757,400.257,404.757,407.007,409.257,415.26,421.758,427.761,433.26,436.257,444.258,449.262,451.512,454.509,456.759,459.009,463.005,467.505,472.005,474.255,480.258,486.756,492.759,498.258,501.255,509.256,514.26,516.51,519.507,522.504" svgx:width="0.5,0.44,0.5,0.44,0.28,0.33,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.67,0.72,0.89,0.89,0.56,0.5,0.5,0.5,0.25,0.25,0.67,0.72,0.67,0.61,0.33,0.89,0.56,0.25,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.67,0.61,0.33,0.89,0.56,0.25,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">behalf of the CAMMS223, CARE-MS I, and CARE-MS II </text>
   <text y="456.099" x="310.014,315.018,317.52,322.02,326.52,331.02,333.27,336.267,340.767,345.267,349.263,352.764,355.266,357.768,362.268,366.264,368.766,373.266,376.263" svgx:width="0.56,0.28,0.5,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.5,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Study Investigators</text>
   <text y="464.583" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="312.941,318.44,322.94,326.936,331.436,335.936,339.932,343.928,348.428,350.678,356.681,360.677,365.177,368.678,373.178,376.679,380.675,383.177,387.173,391.673,395.669,399.665,403.166,405.416,410.915,414.911,418.412,422.408,426.908,430.409,434.405,438.905,441.155,443.405,448.904,453.404,456.905,459.407,461.657,467.66,472.16,474.662,477.164,479.666,484.166,487.667,489.917,492.167,498.17,504.668,506.918,509.168,515.666,520.166,522.668,525.17,529.166,533.666" svgx:width="0.61,0.5,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.25,0.61,0.5,0.39,0.28,0.25,0.67,0.5,0.28,0.28,0.28,0.5,0.39,0.25,0.25,0.67,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Advanced Neurosciences Research, Fort Collins, CO, United </text>
   <text y="478.101" x="310.016,314.516,317.018,321.518,324.02,328.016,331.517,333.767" svgx:width="0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">States, </text>
   <text y="475.583" x="336.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="478.103" x="338.941,344.944,347.447,349.949,354.449,356.951,360.947,365.447,367.949,370.199,376.697,381.197,384.698,389.198,391.7,394.202,398.702,401.204,403.454,409.457,413.453,417.953,420.455,423.956,427.952,430.202,435.206,439.706,444.206,447.707,451.703,456.203,458.453,460.703,466.706,469.208,471.71,476.21,478.712,482.708,484.958,487.46,491.96,495.461,497.711,503.714,507.71,512.21,515.711,520.211,522.713,527.213,531.713,535.709,537.959" svgx:width="0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.56,0.5,0.5,0.39,0.44,0.5,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.25,0.28,0.5,0.39,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Clinical Hospital Centre Zagreb, Clinic for Neurology, </text>
   <text y="489.101" x="310.016,315.02,319.52,324.02,327.521,331.517,336.017,338.267,340.517,346.52,350.021,354.521,359.021,361.523,364.025,368.525,370.775" svgx:width="0.56,0.5,0.5,0.39,0.44,0.5,0.25,0.25,0.67,0.39,0.5,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Zagreb, Croatia, </text>
   <text y="486.583" x="373.024" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="489.103" x="375.949,382.447,386.443,390.943,394.444,398.44,404.938,408.934,411.184,413.434,417.934,420.184,424.684,429.184,433.684,438.184,440.686,443.188,445.438,451.441,455.941,462.439,466.939,471.439,475.939,479.935,482.185,484.435,490.438,494.938,501.436,505.936,509.437,511.939,516.439,520.939,524.935,527.185,529.435,536.932,542.431,544.681" svgx:width="0.72,0.44,0.5,0.39,0.44,0.72,0.44,0.25,0.25,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.28,0.25,0.67,0.5,0.72,0.5,0.5,0.5,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Genzyme, a Sanofi Company, Cambridge, MA, </text>
   <text y="500.101" x="310.015,316.513,321.013,323.515,326.017,330.013,334.513,336.763,341.263,343.765,348.265,350.767,354.763" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United States</text>
   <text y="527.101" x="310.015,316.018,320.518,324.514,329.518,334.018,337.852,342.352,347.356,352.36,357.364,360.361" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="527.101" x="364.681,371.179,373.681,377.677,384.679,387.181,391.681,395.677,400.177,407.179,411.175,415.675,417.925,419.995,422.497,425.998,428.248,430.318,434.314,438.814,443.314,446.311,450.811,455.311,459.307,463.807,466.057,468.128,470.63,475.13,477.38,479.45,484.526,489.026,493.526,495.776,497.846,501.842,506.342,510.842,515.342,517.844,520.841,523.343,527.339,530.84,533.09,535.16,538.157,542.657,545.654" svgx:width="0.72,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.33,0.28,0.44,0.39,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Alemtuzumab is approved in &gt;30 countries for </text>
   <text y="538.099" x="310.015,313.012,317.008,319.51,323.506,328.006,331.507,334.009,338.509,343.009,346.006,349.003,352.999,360.001,362.503,365.005,367.508,370.01,374.51,379.01,380.963,387.965,392.465,394.967,397.469,399.971,404.471,406.973,410.969,412.922,416.423,420.419,422.921,426.917,429.914,434.414,437.915,440.417,443.918,445.871,448.868,454.871,460.874,468.875,473.879,476.876,479.126,481.079,484.076,488.576,490.529,495.029,496.982,500.978,503.48,505.982,510.482,512.984,516.98,520.976,523.478,525.431,527.933,530.93,533.432,537.428,539.93,543.431,545.681" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.25,0.33,0.5,0.25,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapsing-remitting multiple sclerosis (RRMS). In 3 clinical trials, </text>
   <text y="549.097" x="310.015,314.011,316.513,320.509,327.511,330.013,334.513,338.509,343.009,350.011,354.007,358.507,360.757,363.277,367.777,371.773,378.775,383.275,387.775,391.276,393.778,396.775,400.771,403.273,407.27,411.77,414.02,416.539,420.04,424.54,429.04,433.036,436.034,438.536,443.036,446.033,448.283,450.803,454.799,457.634,460.631,463.133,467.129,471.125,475.121,479.621,481.871,484.391,488.891,492.392,494.642,497.162,500.663,505.163,509.663,513.659,518.159,520.661,524.657,529.157,533.153,537.653,542.153,545.654" svgx:width="0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.44,0.33,0.28,0.5,0.33,0.25,0.55,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.55,0.5,0.39,0.25,0.55,0.39,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alemtuzumab demonstrated superior efficacy vs subcutaneous </text>
   <text y="560.095" x="310.015,312.517,317.017,319.519,323.515,326.512,329.509,333.505,336.502,341.002,345.502,348.499,352.999,356.995,359.497,363.493,366.49,370.99,374.986,377.515,380.512,385.516,391.519,394.048,397.045,402.049,408.547,414.55,417.547,422.047,426.043,429.04,431.569,438.067,440.569,443.071,447.571,450.1,454.096,456.625,460.621,465.121,469.621,473.122,475.624,479.125,481.628,485.624,490.124,492.626,495.155,499.151,503.651,508.151,510.68,517.682,521.677,526.177,530.173,534.673,538.669,542.665" svgx:width="0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.33,0.5,0.44,0.28,0.44,0.33,0.5,0.44,0.25,0.33,0.56,0.67,0.25,0.33,0.56,0.72,0.67,0.33,0.5,0.44,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">interferon-beta-1a (SC IFNB-1a) with a consistent and managea-</text>
   <text y="571.093" x="310.015,314.515,317.017,321.013,323.263,325.576,329.077,333.073,336.07,340.066,342.568,347.068,349.318,351.631,356.131,359.128,363.628,366.625,369.127,371.629,375.625,377.875,380.125,381.943,388.441,392.941,397.441,401.941,405.937,408.439,410.689,413.002,420.004,424.0,426.502,429.004,433.504,438.004,442.0,446.5,450.496,454.996,457.246,459.559,462.556,466.552,469.055,473.051,476.552,478.802,481.115,485.615,490.115,493.112,495.614,500.114,504.614,506.864,509.177,513.172,517.672,522.172,524.674,527.672,532.172,534.674,537.176,541.172,545.672" svgx:width="0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.25,0.25,0.55,0.72,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ble safety profile. Annual malignancy rates during controlled </text>
   <text y="582.091" x="310.015,313.516,316.018,320.518,325.018,327.52,331.516,335.017,337.843,344.341,348.337,351.334,355.33,358.156,360.658,365.158,369.154,371.98,375.481,379.477,386.479,390.475,393.301,396.298,400.798,403.795,406.621,410.617,413.119,417.115,424.117,426.619,431.119,435.115,439.615,446.617,450.613,455.113,457.939,461.935,466.435,470.935,473.761,478.765,484.768,487.594,490.591,495.595,502.093,508.096,511.093,515.593,519.589,522.415,525.412,529.912,532.162,536.662,541.162,545.662" svgx:width="0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.78,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.56,0.67,0.25,0.33,0.56,0.72,0.67,0.33,0.5,0.44,0.25,0.33,0.5,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">studies were the same for alemtuzumab and SC IFNB-1a (0.003 </text>
   <text y="593.089" x="310.015,314.011,318.511,322.507,327.007,329.509,333.01,335.512,340.012,344.008,348.004,351.001,353.998,356.248,358.75,363.25,367.246,369.748,374.248,378.748,381.25,385.75,390.25,392.527,395.525,399.521,402.023,406.019,409.52,411.797,414.794,419.294,422.291,424.577,429.077,433.073,436.574,440.57,443.072,445.358,449.354,453.35,455.852,458.354,460.631,464.627,468.623,471.62,475.616,478.118,482.618,487.118,494.12,498.116,501.617,503.894,510.392,514.892,517.394,521.39,525.89,528.176,534.674,538.67,541.667,545.663" svgx:width="0.44,0.5,0.44,0.5,0.28,0.39,0.28,0.5,0.44,0.44,0.33,0.33,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.39,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.25,0.44,0.44,0.33,0.44,0.28,0.5,0.5,0.78,0.44,0.39,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">events/year),including rates for basal cell carcinomas which were </text>
   <text y="604.087" x="310.015,313.516,317.512,321.508,326.008,328.258,334.756,337.258,339.76,344.26,346.51,351.01,355.51,358.012,362.512,364.762,367.264,370.261,374.257,378.253,380.755,387.757,391.753,396.253,398.755,402.257" svgx:width="0.39,0.44,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seen with both treatments.</text>
   <text y="615.085" x="310.015,317.017,322.021,325.018,329.014,333.01,336.007,338.509,343.009,347.005,350.506,353.503" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="615.085" x="357.607,362.476,366.976,369.226,371.08,374.077,378.073,382.573,387.073,390.07,392.572,394.822,396.676,399.178,403.678,407.674,410.176,414.676,418.672,423.172,427.168,431.164,433.414,435.268,439.264,443.764,448.264,450.514,452.368,454.87,459.37,463.87,467.866,471.367,473.617,475.471,479.971,482.969,485.219,487.073,494.075,498.071,500.573,503.075,507.575,512.075,516.071,520.571,524.567,527.069,531.065,534.565,536.815,538.669,541.172,545.672" svgx:width="0.61,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To report incidence and types of malignancies in </text>
   <text y="626.083" x="310.015,314.011,316.513,320.509,327.511,330.013,334.513,338.509,343.009,350.011,354.007,358.507,361.504,364.006,367.003,370.999,374.995,377.497,381.493,385.993,388.243,392.743,396.74,399.242,401.744,405.74,410.24,412.742,416.243,418.493,420.995,425.495,427.745,430.247,434.747,438.743,440.993,448.994,453.998,456.248,460.244,462.746,465.248,469.748,472.25,476.246,480.242,482.744,484.994,487.496,490.493,492.995,496.991,499.493,501.743,506.243,509.24,513.74,518.24,521.237,525.233,532.235" svgx:width="0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alemtuzumab-treated patients in the MS clinical trial program.</text>
   <text y="637.081" x="310.015,318.511,322.507,325.504,330.508,335.008,340.012,343.513,346.51" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="637.081" x="349.534,355.033,359.533,363.529,365.779,366.553,370.549,373.051,377.047,384.049,386.551,391.051,395.047,399.547,406.549,410.545,415.045,417.295,418.069,426.07,431.074,433.324,434.098,438.094,440.596,443.098,447.598,450.1,454.096,458.092,460.594,462.844,463.618,466.12,469.117,471.619,475.615,478.117,480.367,481.141,485.641,488.638,493.138,497.638,500.635,504.632,511.634,513.884,514.658,517.16,521.66,525.656,528.158,532.658,537.158,541.154,545.654" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.78,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The alemtuzumab MS clinical trial program included </text>
   <text y="648.079" x="310.015,312.517,317.017,321.013,323.785,329.788,336.286,344.287,352.288,357.292,361.792,366.292,370.792,373.564,378.064,382.564,386.56,390.061,394.057,396.829,401.329,404.101,407.602,410.104,414.604,419.104,423.604,426.376,429.373,435.871,441.874,447.373,451.873,456.373,460.873,465.373,469.873,474.373,478.873,483.373,486.37,488.62,491.392,497.395,501.895,508.897,513.397,517.393,520.39,522.892,526.393,530.893,535.393,538.165,542.665,545.662" svgx:width="0.28,0.5,0.44,0.25,0.67,0.72,0.89,0.89,0.56,0.5,0.5,0.5,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.67,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the CAMMS223 phase 2 study (NCT00050778), Comparison of </text>
   <text y="659.077" x="310.015,316.513,319.015,323.011,330.013,332.515,337.015,341.011,345.511,352.513,356.509,361.009,363.259,369.478,373.474,377.974,382.474,384.724,390.943,396.946,400.942,405.442,407.944,410.941,413.191,419.41,424.909,427.744,430.741,433.243,437.239,441.235,445.231,449.731,451.981,458.2,460.702,465.202,467.452,473.671,481.672,486.172,488.674,491.177,493.679,498.179,500.681,504.677,506.927,513.146,518.15,522.146,524.648,528.644,531.641,536.141,539.642,542.144,545.645" svgx:width="0.72,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.44,0.5,0.28,0.33,0.25,0.55,0.61,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Alemtuzumab and Rebif Efficacy in Multiple Sclerosis </text>
   <text y="670.075" x="310.015,313.012,319.015,325.513,331.516,337.015,340.012,348.013,353.017,356.014,358.264,359.254,362.251,364.501,365.491,368.488,374.986,380.989,386.488,390.988,395.488,399.988,404.488,408.988,413.488,417.988,422.488,425.485,427.735,428.725,432.721,437.221,441.721,443.971,444.961,447.958,450.955,453.205,454.195,457.192,463.69,469.693,475.192,479.692,484.192,488.692,493.192,497.692,502.192,506.692,511.192,514.189,516.439,517.429,521.929,526.429,530.425,533.926,537.922,540.172,541.162,545.662" svgx:width="0.33,0.67,0.72,0.67,0.61,0.33,0.89,0.56,0.33,0.25,0.55,0.33,0.25,0.55,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.33,0.25,0.55,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(CARE-MS) I (NCT00530348) and II (NCT00530348) phase 3 </text>
   <text y="681.073" x="310.015,313.516,316.018,320.518,325.018,327.52,331.516,335.017,337.267,339.364,343.36,347.86,352.36,354.457,358.453,362.953,365.05,369.55,374.05,378.55,383.05,385.552,390.052,394.552,396.649,400.645,405.145,407.647,411.643,416.143,419.644,422.146,426.646,431.146,433.243,436.24,442.738,448.741,454.24,458.74,463.24,467.74,472.24,476.74,481.24,485.74,490.24,493.237,495.487,497.584,502.588,506.584,509.086,511.588,515.584,520.084,522.586,526.087,528.184,534.682,538.678,541.675,545.671" svgx:width="0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.72,0.67,0.61,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">studies, and an ongoing extension (NCT00930553). Patients were </text>
   <text y="692.071" x="310.015,313.012,317.008,321.508,326.008,330.508,337.51,340.012,344.008,348.004,352.504,354.754,355.465,357.967,362.467,364.717,365.428,369.424,371.926,375.922,382.924,385.426,389.926,393.922,398.422,405.424,409.421,413.921,416.171,416.882,421.382,425.882,428.132,428.842,435.845,440.345,442.595,443.306,446.303,450.299,454.799,459.299,461.549,462.26,466.76,471.26,473.51,474.221,481.223,485.723,487.973,488.684,491.186,495.686,497.936,498.647,504.65,511.148,519.148,527.149,532.154,536.654,541.154,545.654" svgx:width="0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.72,0.89,0.89,0.56,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">randomized to alemtuzumab 12 mg (and 24 mg in CAMMS223 </text>
   <text y="703.069" x="310.015,314.011,318.511,323.011,325.261,327.709,333.712,340.21,346.213,351.712,354.709,362.71,367.714,369.964,372.412,375.409,378.406,381.403,383.653,386.101,390.601,393.598,395.848,398.296,403.3,409.303,411.553,414.001,416.998,422.002,428.5,434.503,437.5,442.0,445.996,448.246,450.694,455.194,459.694,461.944,464.392,471.394,475.39,479.89,482.14,484.588,489.088,491.338,493.786,496.288,498.79,505.792,509.788,513.289,515.539,517.987,524.485,528.481,532.477,536.977,539.479,543.394,545.644" svgx:width="0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.67,0.61,0.33,0.89,0.56,0.25,0.55,0.33,0.33,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.67,0.25,0.55,0.33,0.56,0.72,0.67,0.33,0.5,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.5,0.25,0.55,0.28,0.28,0.78,0.44,0.39,0.25,0.55,0.72,0.44,0.44,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and CARE-MS II) or SC IFNB-1a 44 mcg 3 times weekly. </text>
   <text y="714.067" x="310.015,315.019,317.521,321.517,326.017,330.517,334.513,337.51,342.01,344.512,348.508,352.504,357.004,359.821,362.323,366.823,370.819,373.321,377.821,381.817,386.317,390.313,394.309,397.126,400.123,404.119,406.621,409.123,413.623,417.124,419.941,422.938,427.942,430.939,436.942,440.443,443.44,446.257,452.755,456.751,459.748,463.744,466.561,470.557,474.553,477.055,481.051,485.551,488.053,492.049,494.552,498.548,503.048,505.865,508.367,512.867,515.684,520.184,524.684,528.68,533.18,535.682,538.184,541.181,545.681" svgx:width="0.56,0.28,0.44,0.5,0.5,0.44,0.33,0.5,0.28,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.33,0.44,0.28,0.28,0.5,0.39,0.25,0.33,0.56,0.33,0.67,0.39,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.44,0.28,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Standardized incidence ratios (SIRs) were calculated to quantify </text>
   <text y="725.065" x="310.015,314.011,318.007,322.507,326.503,330.499,333.496,335.746,338.095,341.092,343.594,347.095,351.595,353.845,356.194,358.696,363.196,365.446,367.795,371.791,374.293,378.289,385.291,387.793,392.293,396.289,400.789,407.792,411.788,416.288,419.285,421.787,424.784,428.78,432.776,435.278,439.274,443.774,446.024,448.373,452.873,456.869,459.371,461.873,465.869,470.369,472.871,476.372,478.622,480.971,484.967,489.467,496.469,500.969,504.965,507.962,511.958,516.458,518.708,521.057,527.555,530.057,532.559,537.059,539.309,541.658,545.654" svgx:width="0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cancer risk in alemtuzumab-treated patients compared with a </text>
  </g>
 </g>
</svg>
